Epidermal growth factor receptor (EGFR) exon 20 mutations in non-small-cell lung cancer and resistance to EGFR-tyrosine kinase inhibitors.
about
Not all epidermal growth factor receptor mutations in lung cancer are created equal: Perspectives for individualized treatment strategyClinical features and treatment outcome of non-small cell lung cancer (NSCLC) patients with uncommon or complex epidermal growth factor receptor (EGFR) mutations.Epidermal growth factor receptor exon 20 mutation in lung cancer: types, incidence, clinical features and impact on treatmentCytology smears as excellent starting material for next-generation sequencing-based molecular testing of patients with adenocarcinoma of the lung.Mechanisms of resistance to EGFR tyrosine kinase inhibitors.Screening for major driver oncogene alterations in adenosquamous lung carcinoma using PCR coupled with next-generation and Sanger sequencing methods.Extracellular region of epidermal growth factor receptor: a potential target for anti-EGFR drug discovery.Non-classic EGFR mutations in a cohort of Dutch EGFR-mutated NSCLC patients and outcomes following EGFR-TKI treatment.Valproic acid, an inhibitor of class I histone deacetylases, reverses acquired Erlotinib-resistance of lung adenocarcinoma cells: a Connectivity Mapping analysis and an experimental study.Oroxylin A inhibits invasion and migration through suppressing ERK/GSK-3β signaling in snail-expressing non-small-cell lung cancer cells.Q58736083
P2860
Q26744284-69FF0586-00BD-4640-B5D2-4621A8B2E92CQ33779181-3B804B12-9A64-46D9-9C76-8995C8AB2C95Q33813089-F3162038-7925-4825-9B71-87A5E81A113DQ36135533-93C49F71-F2D0-4951-8E6D-499712078908Q36238664-B8F7DD93-1DF3-4309-A94F-6046523F6FA0Q36628618-9F1E98FA-DCAE-4AF0-BFE7-9B52D0BCDBDBQ38989275-4F48373A-5614-423D-B106-DE50C2DF0B79Q39163315-1C66934E-FB17-40AD-8B54-822A718C69F3Q41837321-F3494802-72A9-4978-A39E-08864D9F9686Q53208177-CBA4E54B-545A-4B95-A48B-76BA9FC7E97FQ58736083-3642FB39-0723-4534-9FE4-F72D436D55D2
P2860
Epidermal growth factor receptor (EGFR) exon 20 mutations in non-small-cell lung cancer and resistance to EGFR-tyrosine kinase inhibitors.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Epidermal growth factor recept ...... FR-tyrosine kinase inhibitors.
@en
type
label
Epidermal growth factor recept ...... FR-tyrosine kinase inhibitors.
@en
prefLabel
Epidermal growth factor recept ...... FR-tyrosine kinase inhibitors.
@en
P2093
P2860
P1476
Epidermal growth factor recept ...... FR-tyrosine kinase inhibitors.
@en
P2093
Dong Bok Shin
Eun Kyung Cho
Ha Yeon Lee
Hee Kyung Ahn
Hyun Sun Woo
Inkeun Park
Jae Hoon Lee
Jinny Park
Junshik Hong
Sun Jin Sym
P2860
P2888
P304
P356
10.1007/S10637-014-0146-X
P577
2014-08-23T00:00:00Z